December 28, 2016 / 12:11 PM / 7 months ago

BRIEF-Ascendance Biotechnology licenses the right to manufacture and sell cytiva cardiomyocytes

1 Min Read

Dec 28 (Reuters) - General Electric Co

* Ascendance biotechnology licenses the right to manufacture, market and sell cytiva cardiomyocytes

* Ascendance biotechnology- execution of an agreement with ge healthcare providing ascendance right to manufacture, market and sell ge healthcare cytiva Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below